Site navigation

The Supreme Court in the case of Novartis AG v. Union of India rejected the patent of which drug?

In Novartis AG v. Union of India, the Supreme Court rejected the patent claim over the beta-crystalline form of imatinib mesylate, marketed as "Gleevec", holding that the…

Choose your answer

The Supreme Court in the case of Novartis AG v. Union of India rejected the patent of which drug?

Select one answer
Answer and explanation

Correct answer A

In Novartis AG v. Union of India, the Supreme Court rejected the patent claim over the beta-crystalline form of imatinib mesylate, marketed as "Gleevec", holding that the incremental modification failed the enhanced efficacy test under Section 3(d) of the Patents Act, 1970.

Practice for these exams

Related exam syllabi

Related questions in this topic